Full text is available at the source.
The Expanding Scope of GLP-1 Receptor Agonists: Six Uses Beyond Diabetes
Six New Uses of GLP-1 Receptor Agonists Beyond Diabetes
AI simplified
Abstract
GLP-1 receptor agonists (GLP-1RAs) may induce clinically meaningful weight loss in individuals with overweight or obesity.
- GLP-1RAs were originally developed for glycemic control in type 2 diabetes but are now being explored for various other health conditions.
- Research indicates that GLP-1RAs may provide cardiovascular benefits and protect kidney function.
- They show potential in managing obesity-related conditions such as obstructive sleep apnea and metabolic-associated liver disease.
- Preliminary data suggest GLP-1RAs could have roles in treating substance use disorders, including alcohol and nicotine dependence.
- Despite their benefits, GLP-1RAs are associated with side effects and high costs, affecting patient access.
AI simplified